Shimadzu Wins R&D 100 Award for Nexera Unified Chromatography System
News Nov 24, 2015
Shimadzu Corporation announces that it has won an R&D 100 award for the development of its Nexera UC Unified Chromatography system. The award from R&D magazine recognizes Shimadzu’s Nexera UC system as one of the 100 most technically significant new products of the year in the analytical and testing category. R&D Magazine chose the Nexera UC system because its fully automated technology opens up new analytical opportunities in many fields, including food products, drug discovery and delivery, chemicals, pharmaceuticals, and cleaning validation.
With industry-leading throughput and superior levels of sensitivity, the system eliminates the need for complicated sample pre-treatment and reduces the possibility of human error during analysis.
“We are honored that the Nexera UC system was recognized as one of the top revolutionary innovations in the world, and we are excited about its positive impact in the analytical world,” said Shuzo Maruyama, General Manager, Analytical & Measurement Instruments Division. “This award is testament to the Shimadzu engineers and developers who strive to not just make the highest quality analytical products, but to improve life for everyone by addressing today’s most crucial scientific research challenges.”
For more information on Shimadzu’s Nexera UC unified chromatography system, go to http://www.ssi.shimadzu.com/products/product.cfm?product=nexera_uc.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Simple Sugar Prevents Neurodegeneration in Lysosomal Storage DiseaseNews
New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)READ MORE